Fulgent Genetics (FLGT) Shares Outstanding (Weighted Average) (2015 - 2026)

Fulgent Genetics has disclosed Shares Outstanding (Weighted Average) across 12 years of filings, most recently posting $30.9 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $30.9 million, changed 0.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $30.9 million (changed 0.16% YoY), and the FY2025 annual result was $30.8 million, up 1.79% from the prior year.
• Shares Outstanding (Weighted Average) came in at $30.9 million for Q1 2026 at Fulgent Genetics, roughly flat from $30.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $30.9 million in Q1 2026 to a low of $29.5 million in Q1 2023.
• The 5-year median for Shares Outstanding (Weighted Average) is $30.2 million (2022), against an average of $30.2 million.
• Across the five-year window, Shares Outstanding (Weighted Average) climbed 4.87% in 2022 and fell 2.31% in 2023, its largest moves.
• Fulgent Genetics' Shares Outstanding (Weighted Average) stood at $30.1 million in 2022, then declined by 1.04% to $29.8 million in 2023, then rose by 1.51% to $30.2 million in 2024, then rose by 1.79% to $30.8 million in 2025, then gained by 0.34% to $30.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $30.9 million (Q1 2026), $30.8 million (Q4 2025), and $30.7 million (Q3 2025), per Business Quant data.